China Biologic Products Commences Trading on OTC Bull... ( TAI'AN CITY China March 4 /Xinhua...)

China Biologic Products Commences Trading on OTC Bulletin Board

Date:3/4/2008

TAI'AN CITY, China, March 4 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on February 29, 2008, it's common stock was approved for quotation on the Over-the-Counter Bulletin Board (the "OTCBB") maintained by the Financial Industry Regulatory Authority (FINRA).

"We are pleased to have our stock quoted on the OTCBB," said Mr. Stanley Wong, CEO of China Biologic Products. "This is an important milestone for us as we seek to expand our list of potential investors and increase both our liquidity and visibility in the market."

The Company's stock is now trading under the symbol CBPO.OB.

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention diseases.

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of China Biologic Products, Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements," including statements regarding: the ability of the Company to expand its list of potential investors and increase its liquidity and visibility in the market or otherwise achieve its commercial objectives; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
2. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
3. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
4. China Shenghuo to Market 12Ways(R) Skin Care Products in the U.S. through Agreement with Home Shopping Group
5. China Pharma Appoints Three Independent Non-Executive Directors
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities
8. China Agro-Technology Appoints New CEO
9. Historic Breakthrough in Fighting Childrens Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
10. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
11. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results

Post Your Comments:

(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...

(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...

(Date:5/20/2013)... 2013 Today, at the American Psychiatric Association ... James McGough , M.D., M.S., principal ... Institute for Neuroscience and Human Behavior and ... University of California Los Angeles (UCLA), and director of ... and ADHD at UCLA, presented the results of a ...

(Date:5/20/2013)... SAN DIEGO , May 20, 2013 Dr. ... the field of nucleic acid research, recently launched a ... Zone In with Zon ( zon.trilinkbiotech.com ), focuses on ... posts include interviews with industry thought leaders, discussions of ... publications and more. Dr. Zon (PhD ...

Breaking Biology Technology:Phosphagenics Signs Research Agreement with the Agricultural Research Service 2 New Laboratory Temperature Controller by Oven Industries 2 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4 Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5 Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2

[0] Phosphagenics Signs Research Agreement with the Agricultural Research Service [0] New Laboratory Temperature Controller by Oven Industries [0] Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)[0] Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies

... Investment Conference on... -- HARBIN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- ... ... --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...

... Calif., Sept. 7 / PRNewswire/ -- Transdel ... announced that Transdel management will present a company overview at ... York City on Monday, September 13, 2010 at 4:05 p.m. ... webcast via the Internet by visiting the Investor Relations section ...

... Exclusive Partnership Agreements for Immunotherapy Tablets in Japan -- ANTONY, France, September 6, 2010 ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...

Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan

(Date:5/20/2013)... of the planet, inhales carbon dioxide as it exudes oxygen. ... that eventually fall to the ground to decompose or get ... recently people believed much of the rain forest,s carbon floated ... ocean. University of Washington research showed a decade ago that ... open the question of how that was possible, since bark ...

(Date:5/20/2013)... University of Bristol and published online today in the ... how the brain and inner ear developed in dinosaurs. ... Sciences, together with Tom Hbner from the Niederschsische Landesmuseum ... year old dinosaurs. , The two palaeontologists studied different ... a very young (juvenile) individual of approximately three ...

(Date:5/19/2013)... of California, Davis have engineered a strain of photosynthetic ... They report their findings today at the 113th General ... this work, we used synthetic biology approaches to probe ... light energy for growth) cyanobacterial metabolism for the ability ... lead researcher on the study. He is part ...

Breaking Biology News(10 mins):Amazon River exhales virtually all carbon taken up by rain forest 2 Amazon River exhales virtually all carbon taken up by rain forest 3 Fossil brain teaser 2

[0] Amazon River exhales virtually all carbon taken up by rain forest [0] Fossil brain teaser [0] Engineered microbes grow in the dark

... newborn described as a "happy blue baby" because of ... small mark in medical history when one of her ... River mutation. Scientists have identified hundreds of mutations ... protein that carries oxygen in everyone,s red blood cells. ...

... Bethesda, MD "Super bugs," which can cause wide-spread disease ... conventional antibiotics, still have their weaknesses. A team of ... presented in lipid (fatty) mixtures can significantly boost the ... This discovery was published online in The FASEB ...

... has awarded the University of Colorado Boulder a ... of long-term ecological changes in Colorado,s high mountains, ... Awarded to CU-Boulder,s Institute of Arctic and ... and students, including undergraduates, to continue key environmental ...

Cached Biology News:Hematologist discovers, names the 'Toms River' blood mutation in N.J. family 2 Scientists develop a fatty 'kryptonite' to defeat multidrug-resistant 'Super bugs' 2 NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research 2 NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research 3 NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research 4

Hematologist discovers, names the 'Toms River' blood mutation in N.J. family Scientists develop a fatty 'kryptonite' to defeat multidrug-resistant 'Super bugs' NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research

OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...

...

... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...

Biology Products:

OPTIMIX KIT FOR EUKARYOTE from Thermo Scientific Expand High Fidelity PCR System, dNTPack (Not available in US) from Roche Applied Science Human Interferon Gamma Bioassay Services from PBL InterferonSource Human Interferon Beta Bioassay Services from PBL InterferonSource